Family Medicine Doctors in Blanding, UT Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Anna M Day, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 799 So 200 W, Blanding, UT 84511 Phone: 435-678-3601 Fax: 435-678-3610 |
 Dr. Mahana S Fisher, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 804 N 400 W, Blanding, UT 84511 Phone: 435-678-2254 Fax: 435-678-2534 |
Lloyd Val Jones, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 S 300 W, Blanding, UT 84511 Phone: 435-678-3601 Fax: 435-678-3610 |
News Archive
Quark Pharmaceuticals closes $10M private financing round
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced the closing of a private financing by the existing investors of Quark totaling an aggregate of $10 million. The investors are funds of the prestigious SBI Holdings Group in Japan. In connection with the financing, Mr. Yoshitaka Kitao, CEO of SBI Holdings, Inc. and Mr. Robert Takeuchi, Director of SBI Investment Co., Ltd. will become members of the Quark board of directors.
Total Immersion adds Eveo as Certified D'Fusion Reseller to partner network
Total Immersion, the global leader in augmented reality (AR), today announced the addition of Eveo as a Certified D'Fusion Reseller to its North American Partner network, the world's largest network dedicated to AR.
Glioma stem cells can change their metabolic state at will, finds study
The metabolic state of glioma stem cells, which give rise to deadly glioblastomas, is significantly different from that of the brain cancer cells to which they give birth, a factor which helps those stem cells avoid treatment and cause recurrence later.
Patient and partner focus needed in rehab after prostatectomy
Most patients who undergo radical prostatectomy are keen to attend a rehabilitation program to help recover sexual potency, but the process can be frustrating and demanding, with high patient dropout rates, say researchers.
Cytogen issued new patent covering oral drug delivery agents
Cytogen Corporation has announced that it has been issued United States patent number 7,135,457 covering its oral drug delivery agents - random peptide compositions that bind to gastro-intestinal tract (GIT) transport receptors.
› Verified 3 days ago